CAP Chemistry Evaluation 2014

ORIGINAL EVALUATION
C-A 2014
INSTITUTION:
ATTENTION:
CAP NUMBER:
KIT INFORMATION:
COPIED TO:
IMPORTANT NOTES:
LEGEND:

Chemistry

NYS Dept of Health
Albany NY 12201-0509
Carol Wenzel BS,MT(ASCP)
1258511-01
Kit ID:
27368712

Kit#

1

Kit Mailed:
3/17/2014

Original Evaluation:
5/19/2014

Next Mailing Date:
6/2/2014

CMS (33D0654341)
Evaluations for those laboratories reporting second instrument results can be obtained from e-LAB Solutions at www.cap.org.
Exception Reason Codes appearing in this evaluation:
[22] = Result is outside the method/instrument reportable range.

Reviewed By

Date

The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.

0003

Page 1 of 9

CAP Number:
Institution:
Attention:
City / State:

Kit# 1
1258511-01
NYS Dept of Health
Carol Wenzel BS,MT(ASCP)
Albany NY 12201-0509

EVALUATION

C-A 2014

ORIGINAL
Test
Unit of Measure
Peer Group

Specimen

Kit ID: 27368712
Kit Mailed: 3/17/2014
Original Evaluation: 5/19/2014

Your
Result

Chemistry

Evaluation and Comparative Method Statistics
No. of
Limits of Acceptability
Labs
Lower
Upper
Mean
S.D.I
S.D.

Your
Grade

Chloride
mmol/L
ION SELECT ELECT DIL
ROCHE COBAS c500 SER

CHM-01
CHM-02
CHM-03
CHM-04
CHM-05

103
101
119
80
101

101.4
99.6
117.9
78.4
99.7

1.3
1.3
1.4
1.4
1.4

649
656
654
652
654

+1.2
+1.0
+0.8
+1.2
+1.0

96
94
111
74
94

107
105
124
83
105

Acceptable
Acceptable
Acceptable
Acceptable
Acceptable

Cholesterol
mg/dL
ENZYMATIC
ROCHE COBAS c500 SER

CHM-01
CHM-02
CHM-03
CHM-04
CHM-05

103.00
159.00
236.00
191.00
159.00

106.587
162.785
240.462
196.301
162.888

2.914
3.600
5.051
4.099
3.461

592
594
592
592
593

-1.2
-1.1
-0.9
-1.3
-1.1

95.92
146.50
216.41
176.67
146.59

117.25
179.07
264.51
215.94
179.18

Acceptable
Acceptable
Acceptable
Acceptable
Acceptable

Creatinine, serum
mg/dL
KINETIC ALK. PICRATE
ROCHE COBAS c500 SER

CHM-01
CHM-02
CHM-03
CHM-04
CHM-05

7.22
4.23
0.68
2.35
4.23

7.178
4.255
0.751
2.381
4.260

0.230
0.161
0.157
0.086
0.150

198
201
201
200
201

+0.2
-0.2
-0.5
-0.4
-0.2

6.10
3.61
0.45
2.02
3.62

8.26
4.90
1.06
2.74
4.90

Acceptable
Acceptable
Acceptable
Acceptable
Acceptable

Glucose, serum
mg/dL
HEXOKINASE, UV
ROCHE COBAS c500 SER

CHM-01
CHM-02
CHM-03
CHM-04
CHM-05

96.0
134.0
57.0
290.0
134.0

96.41
135.68
58.17
291.13
135.92

2.01
2.62
1.24
5.50
2.69

622
621
622
622
622

-0.2
-0.6
-0.9
-0.2
-0.7

86.7
122.1
52.1
262.0
122.3

106.1
149.3
64.2
320.3
149.6

Acceptable
Acceptable
Acceptable
Acceptable
Acceptable

Plot of the Relative Distance of Your Results from
Target as Percentages of allowed Deviation

Survey

-100------------Mean-----------+100

C-A 2014
C-C 2013
C-B 2013

C-A 2014
C-C 2013
C-B 2013

C-A 2014
C-C 2013
C-B 2013

C-A 2014
C-C 2013
C-B 2013

The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.

0003

Page 2 of 9

CAP Number:
Institution:
Attention:
City / State:

Kit# 1
1258511-01
NYS Dept of Health
Carol Wenzel BS,MT(ASCP)
Albany NY 12201-0509

EVALUATION

C-A 2014

ORIGINAL
Test
Unit of Measure
Peer Group

Specimen

Kit ID: 27368712
Kit Mailed: 3/17/2014
Original Evaluation: 5/19/2014

Your
Result

Chemistry

Evaluation and Comparative Method Statistics
No. of
Limits of Acceptability
Labs
Lower
Upper
Mean
S.D.I
S.D.

Your
Grade

hCG, serum, quant
mIU/mL (IU/L)
ROCHE e411/ELECSYS BET

CHM-01
CHM-02
CHM-03
CHM-04
CHM-05

11.4
175.0
471.3
221.4
179.4

11.24
173.43
463.60
215.02
174.36

0.66
10.59
25.87
12.27
9.57

118
119
116
117
118

+0.2
+0.1
+0.3
+0.5
+0.5

9.2
141.6
385.9
178.2
145.6

13.3
205.2
541.3
251.9
203.1

Acceptable
Acceptable
Acceptable
Acceptable
Acceptable

Potassium, serum
mmol/L
ION SELECT ELECT DIL
ROCHE COBAS c500 SER

CHM-01
CHM-02
CHM-03
CHM-04
CHM-05

6.5
4.8
4.4
2.0
4.8

6.55
4.89
4.45
2.03
4.89

0.10
0.09
0.09
0.08
0.09

649
653
659
647
655

-0.5
-1.0
-0.6
-0.3
-1.0

6.0
4.3
3.9
1.5
4.3

7.1
5.4
5.0
2.6
5.4

Acceptable
Acceptable
Acceptable
Acceptable
Acceptable

Sodium, serum
mmol/L
ION SELECT ELECT DIL
ROCHE COBAS c500 SER

CHM-01
CHM-02
CHM-03
CHM-04
CHM-05

140
139
156
120
139

139.1
138.4
155.7
119.5
138.6

1.6
1.3
1.5
1.4
1.4

652
646
641
648
646

+0.6
+0.4
+0.2
+0.4
+0.2

135
134
151
115
134

144
143
160
124
143

Acceptable
Acceptable
Acceptable
Acceptable
Acceptable

Triglycerides
mg/dL
ENZ COLOR w/o GB w/SB
ROCHE COBAS c500 SER

CHM-01
CHM-02
CHM-03
CHM-04
CHM-05

95.00
144.00
253.00
129.00
144.00

93.531
141.954
251.738
127.962
142.131

3.090
4.151
8.400
4.343
4.200

13
13
13
13
13

+0.5
+0.5
+0.2
+0.2
+0.4

70.14
106.46
188.80
95.97
106.59

116.92
177.45
314.68
159.96
177.67

Acceptable
Acceptable
Acceptable
Acceptable
Acceptable

Plot of the Relative Distance of Your Results from
Target as Percentages of allowed Deviation

Survey

-100------------Mean-----------+100

C-A 2014
C-C 2013
C-B 2013

C-A 2014
C-C 2013
C-B 2013

C-A 2014
C-C 2013
C-B 2013

C-A 2014
C-C 2013
C-B 2013

The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.

0003

Page 3 of 9

CAP Number:
Institution:
Attention:
City / State:

Kit# 1
1258511-01
NYS Dept of Health
Carol Wenzel BS,MT(ASCP)
Albany NY 12201-0509

EVALUATION

C-A 2014

ORIGINAL
Test
Unit of Measure
Peer Group

Specimen

Kit ID: 27368712
Kit Mailed: 3/17/2014
Original Evaluation: 5/19/2014

Your
Result

Chemistry

Evaluation and Comparative Method Statistics
No. of
Limits of Acceptability
Labs
Lower
Upper
Mean
S.D.I
S.D.

Your
Grade

Urea Nitrogen
mg/dL
UREASE WITH GLDH
ROCHE COBAS c500 SER

CHM-01
CHM-02
CHM-03
CHM-04
CHM-05

10.7
20.4
19.2
40.4
20.5

10.76
20.10
18.90
40.12
20.13

0.41
0.59
0.53
1.01
0.56

670
672
666
665
665

-0.1
+0.5
+0.6
+0.3
+0.7

8.7
18.1
16.8
36.5
18.1

12.8
22.1
20.9
43.8
22.2

Acceptable
Acceptable
Acceptable
Acceptable
Acceptable

Triiodothyronine (T3)
ng/dL
ROCHE e411/ELECSYS

CHM-01
CHM-02
CHM-03
CHM-04
CHM-05

77.7
225.7
419.3
247.0
230.5

81.96
242.63
439.78
270.69
249.14

7.77
14.69
31.10
16.88
18.27

36
36
36
36
37

-0.5
-1.2
-0.7
-1.4
-1.0

58.6
198.5
346.4
220.0
194.3

105.3
286.7
533.1
321.4
304.0

Acceptable
Acceptable
Acceptable
Acceptable
Acceptable

Thyroxine
ug/dL
ROCHE e411/ELECSYS

CHM-01
CHM-02
CHM-03
CHM-04
CHM-05

2.4
5.8
13.5
6.0
5.8

2.62
6.37
14.00
6.08
6.46

0.23
0.48
1.03
0.44
0.50

55
56
54
56
55

-0.9
-1.2
-0.5
-0.2
-1.3

1.6
5.0
11.1
4.8
5.1

3.7
7.7
16.8
7.3
7.8

Acceptable
Acceptable
Acceptable
Acceptable
Acceptable

Thyroid Stim Hormone
uIU/mL (mIU/L)
ROCHE e411/ELECSYS

CHM-01
CHM-02
CHM-03
CHM-04
CHM-05

0.75
3.75
10.75
1.30
3.80

0.752
3.765
10.824
1.284
3.775

0.029
0.138
0.480
0.050
0.146

145
146
148
146
147

-0.1
-0.1
-0.2
+0.3
+0.2

0.66
3.35
9.38
1.13
3.33

0.84
4.18
12.27
1.44
4.22

Acceptable
Acceptable
Acceptable
Acceptable
Acceptable

Plot of the Relative Distance of Your Results from
Target as Percentages of allowed Deviation

Survey

-100------------Mean-----------+100

C-A 2014
C-C 2013
C-B 2013

C-A 2014
C-C 2013
C-B 2013

C-A 2014
C-C 2013
C-B 2013

C-A 2014
C-C 2013
C-B 2013

The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.

0003

Page 4 of 9

CAP Number:
Institution:
Attention:
City / State:

Kit# 1
1258511-01
NYS Dept of Health
Carol Wenzel BS,MT(ASCP)
Albany NY 12201-0509

EVALUATION

C-A 2014

ORIGINAL
Test
Unit of Measure
Peer Group

Digoxin
ng/mL
KIMS
ROCHE COBAS c500 SER
Method/Instrument

Phenobarbital
ug/mL
KIMS
ROCHE COBAS c500 SER

Phenytoin
ug/mL
KIMS
ROCHE COBAS c500 SER

Specimen
CHM-01
CHM-02
CHM-03
CHM-04
CHM-05
CHM-01
CHM-02
CHM-03
CHM-04
CHM-05
CHM-01
CHM-02
CHM-03
CHM-04
CHM-05
CHM-01
CHM-02
CHM-03
CHM-04
CHM-05

Kit ID: 27368712
Kit Mailed: 3/17/2014
Original Evaluation: 5/19/2014

Your
Result

Chemistry

Evaluation and Comparative Method Statistics
No. of
Limits of Acceptability
Labs
Lower
Upper
Mean
S.D.I
S.D.

Your
Grade

Plot of the Relative Distance of Your Results from
Target as Percentages of allowed Deviation

Survey

-100------------Mean-----------+100

C-A 2014

0.7
1.4
2.7
1.5
1.4
15.3
34.3

0.07
0.09
0.12
0.08
0.08
0.79
1.29
5.03
1.77
1.64

97
98
99
99
100
96
95
88
97
96

-0.4
+0.3
+1.1
+0.1
+0.5
-0.3
-0.3

0.5
1.0
2.0
1.1
1.0
12.4
27.7

36.0
35.4

0.73
1.37
2.58
1.50
1.36
15.56
34.64
68.41
35.71
34.73

1.0
1.7
3.1
1.8
1.7
18.7
41.6

+0.2
+0.4

28.5
27.7

Acceptable
Acceptable
Acceptable
Acceptable
Acceptable
Acceptable
Acceptable
[22]
42.9 Acceptable
41.7 Acceptable

5.6
13.1
13.7
27.4
13.1

5.06
12.97
13.74
27.70
12.95

0.46
0.70
0.88
1.85
0.82

117
116
119
117
119

+1.2
+0.2
0.0
-0.2
+0.2

3.7
9.7
10.3
20.7
9.7

6.4
16.3
17.2
34.7
16.2

Acceptable
Acceptable
Acceptable
Acceptable
Acceptable

C-A 2014

C-A 2014

The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.

0003

Page 5 of 9

CAP Number:
Institution:
Attention:
City / State:

Kit# 1
1258511-01
NYS Dept of Health
Carol Wenzel BS,MT(ASCP)
Albany NY 12201-0509

EVALUATION

C-A 2014

ORIGINAL
Test
Unit of Measure
Peer Group

Theophylline
ug/mL
KIMS
ROCHE COBAS c500 SER

Vancomycin
ug/mL or mg/L
HOMOGENEOUS EIA
ROCHE COBAS c500 SER
Method/Instrument

Pseudocholinesterase
U/mL
ROCHE COBAS c500 SER
ROCHE/37 C

Specimen
CHM-01
CHM-02
CHM-03
CHM-04
CHM-05
CHM-01
CHM-02
CHM-03
CHM-04
CHM-05
CHM-01
CHM-02
CHM-03
CHM-04
CHM-05
C7-01

Kit ID: 27368712
Kit Mailed: 3/17/2014
Original Evaluation: 5/19/2014

Your
Result

Chemistry

Evaluation and Comparative Method Statistics
No. of
Limits of Acceptability
Labs
Lower
Upper
Mean
S.D.I
S.D.

21.3
24.5
10.9
24.6

21.23
24.29
10.63
43.83
24.33

0.69
0.69
0.36
2.42
0.82

77
77
77
74
78

+0.1
+0.3
+0.8

15.9
18.2
7.9

+0.3

18.2

Your
Grade

26.6 Acceptable
30.4 Acceptable
13.3 Acceptable
[22]
30.5 Acceptable

Plot of the Relative Distance of Your Results from
Target as Percentages of allowed Deviation

Survey

-100------------Mean-----------+100

C-A 2014

C-A 2014

7.80
22.20
44.90
24.00
21.80
8.0

7.889
21.614
47.033
24.192
21.564
8.10

0.521
0.976
2.281
1.055
0.974
0.24

401
394
398
397
394
15

-0.2
+0.6
-0.9
-0.2
+0.2
-0.4

6.32
18.68
40.19
21.02
18.64
5.6

9.46
24.55
53.88
27.36
24.49
10.6

Acceptable
Acceptable
Acceptable
Acceptable
Acceptable
Acceptable
C-A 2014
C-C 2013
C-B 2013

The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.

0003

Page 6 of 9

CAP Number:
Institution:
Attention:
City / State:

Kit# 1
1258511-01
NYS Dept of Health
Carol Wenzel BS,MT(ASCP)
Albany NY 12201-0509

EVALUATION

Kit ID: 27368712
Kit Mailed: 3/17/2014
Original Evaluation: 5/19/2014

C-A 2014

ORIGINAL

Chemistry

CMS Peformance Summary for Analytes Regulated Under the Clinical Laboratory Improvement Amendments of 1988
CLIA ID #:
33D0654341
Proficiency Event
2013
2
Regulated Analyte

Subspecialty :
Proficiency Event
2013
3

Test Event

Current Event
Performance
Interpretation

Cumulative CLIA
'88 Performance
Interpretation

Test Event

Score

%

Score

%

Score

%

Chloride

C-B

5 /5

100

C-C

5 /5

100

C-A

5 /5

100

Satisfactory

Successful

Cholesterol, Total

C-B

5 /5

100

C-C

5 /5

100

C-A

5 /5

100

Satisfactory

Successful

Creatinine

C-B

5 /5

100

C-C

5 /5

100

C-A

5 /5

100

Satisfactory

Successful

Glucose

C-B

5 /5

100

C-C

5 /5

100

C-A

5 /5

100

Satisfactory

Successful

Potassium

C-B

5 /5

100

C-C

5 /5

100

C-A

5 /5

100

Satisfactory

Successful

Sodium

C-B

5 /5

100

C-C

5 /5

100

C-A

5 /5

100

Satisfactory

Successful

Triglycerides

C-B

5 /5

100

C-C

5 /5

100

C-A

5 /5

100

Satisfactory

Successful

Urea Nitrogen

C-B

5 /5

100

C-C

5 /5

100

C-A

5 /5

100

Satisfactory

Successful

40/40

100

40/40

100

40/40

100

Satisfactory

Routine Chemistry

Test Event

Routine Chemistry
Proficiency Event
2014
1

Successful

The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.

0003

Page 7 of 9

CAP Number:
Institution:
Attention:
City / State:

Kit# 1
1258511-01
NYS Dept of Health
Carol Wenzel BS,MT(ASCP)
Albany NY 12201-0509

EVALUATION

Kit ID: 27368712
Kit Mailed: 3/17/2014
Original Evaluation: 5/19/2014

C-A 2014

ORIGINAL

Chemistry

CMS Peformance Summary for Analytes Regulated Under the Clinical Laboratory Improvement Amendments of 1988
CLIA ID #:
33D0654341
Proficiency Event
2013
2
Regulated Analyte

Subspecialty :
Proficiency Event
2013
3

Test Event

Current Event
Performance
Interpretation

Cumulative CLIA
'88 Performance
Interpretation

Test Event

Score

%

Score

%

Score

%

hCG

C-B

5 /5

100

C-C

5 /5

100

C-A

5 /5

100

Satisfactory

Successful

Triiodothyronine (T3)

C-B

5 /5

100

C-C

5 /5

100

C-A

5 /5

100

Satisfactory

Successful

TSH

C-B

5 /5

100

C-C

5 /5

100

C-A

5 /5

100

Satisfactory

Successful

Thyroxine (T4, Total)

C-B

5 /5

100

C-C

5 /5

100

C-A

5 /5

100

Satisfactory

Successful

20/20

100

20/20

100

20/20

100

Satisfactory

Endocrinology

Test Event

Endocrinology
Proficiency Event
2014
1

Successful

The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.

0003

Page 8 of 9

CAP Number:
Institution:
Attention:
City / State:

Kit# 1
1258511-01
NYS Dept of Health
Carol Wenzel BS,MT(ASCP)
Albany NY 12201-0509

EVALUATION

Kit ID: 27368712
Kit Mailed: 3/17/2014
Original Evaluation: 5/19/2014

C-A 2014

ORIGINAL

Chemistry

CMS Peformance Summary for Analytes Regulated Under the Clinical Laboratory Improvement Amendments of 1988
CLIA ID #:
33D0654341
Proficiency Event
2013
2
Regulated Analyte

Subspecialty :
Proficiency Event
2013
3

Test Event

Current Event
Performance
Interpretation

Cumulative CLIA
'88 Performance
Interpretation

Test Event

Score

%

Score

%

Score

%

Blood Lead

BL-B

5 /5

100

BL-C

5 /5

100

BL-A

5 /5

100

Satisfactory

Successful

Digoxin

Z-B

5 /5

100

Z-C

5 /5

100

C-A

5 /5

100

Satisfactory

Successful

Phenobarbital

Z-B

5 /5

100

Z-C

5 /5

100

C-A

5 /5

100

Satisfactory

Successful

Phenytoin

Z-B

5 /5

100

Z-C

5 /5

100

C-A

5 /5

100

Satisfactory

Successful

Theophylline

Z-B

5 /5

100

Z-C

5 /5

100

C-A

5 /5

100

Satisfactory

Successful

25/25

100

25/25

100

25/25

100

Satisfactory

Toxicology

Test Event

Toxicology
Proficiency Event
2014
1

Successful

The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory.

0003

Page 9 of 9